Late verification of primary ciliary dyskinesia and new diagnostic possibilities
https://doi.org/10.18093/0869-0189-2024-4585
Abstract
Cystic fibrosis (CF) and primary ciliary dyskinesia (PCD) are hereditary lung diseases. Cystic fibrosis is a monogenic disease, while PCD has a genetically heterogeneous nature and is 2 times less common than CF. More than 50 genes are responsible for PCD, one of them being the DNAAF11 gene (LRRC6 according to the previous nomenclature) – the assembly factor of the external and internal dynein arms. When the mutation is present, components of the dynein arms remain in the cytoplasm of cells. The aim is to present a clinical case of a newly diagnosed PCD in a 44-year-old woman with a homozygous pathogenic variant of the nucleotide sequence NM_012472.6:c.436G>C in the DNAAF11 gene. This clinical case demonstrates the complexity of verification and differential diagnosis of cystic fibrosis and primary ciliary dyskinesia, the features of the disease, and the modern diagnostic capabilities. The difficulties and some typical mistakes in the management of such patients are presented. Conclusion. The presented clinical case illustrates the difficulties of PCD diagnosis. It demonstrates that such patients need a comprehensive examination for a thorough differential diagnosis to exclude diseases with a similar clinical picture. The long-term follow-up is carried out by a multidisciplinary team of specialists and must include microbiological monitoring.
Keywords
About the Authors
E. I. KondratyevaRussian Federation
Elena I. Kondratyeva, Doctor of Medicine, Professor, Head of the Scientific and Clinical Department of cystic fibrosis, Head of the Department of Genetics of Respiratory System Diseases, Institute of Higher and Additional Professional Education; Head of the Cystic Fibrosis Center
ul. Moskvorechye 1, Moscow, 115522;
ul. Kominterna 124A, build. 1, Moskovskaya obl., Mytishchi, 141009;
tel.: (495) 111-03-03
Competing Interests:
No conflict of interest was declared by the authors.
T. A. Kyian
Russian Federation
Tatiana A. Kyian, Candidate of Medicine, Senior Researcher, Scientific and Clinical Department of Cystic Fibrosis; Senior Researcher; Head of the Cystic Fibrosis Center
Scopus ID: 57205414678;
ul. Moskvorechye 1, Moscow, 115522;
ul. Kominterna 124A, build. 1, Moskovskaya obl., Mytishchi, 141009;
tel.: (499) 324-15-01
Competing Interests:
No conflict of interest was declared by the authors.
E. E. Bragina
Russian Federation
Elizaveta E. Bragina, Doctor of Biology, Senior Researcher, Department of Electron Microscopy, The A.N.Belozersky Institute оf Physico-Chemical Biology; Leading Researcher, Laboratory of genetics of reproductive disorders
ul. Moskvorechye 1, Moscow, 115522;
Leninskye gory 1, build. 40, Moscow, 119992;
tel.: (495) 939-53-59
Competing Interests:
No conflict of interest was declared by the authors.
A. G. Demchenko
Russian Federation
Anna G. Demchenko, Researcher, Genome Editing Laboratory
ul. Moskvorechye 1, Moscow, 115522;
tel.: (499) 324-35-79
Competing Interests:
No conflict of interest was declared by the authors.
M. V. Tarasov
Russian Federation
Maxim V. Tarasov, Laboratory Research Assistant, Cystic Fibrosis Clinical Research Department
ul. Moskvorechye 1, Moscow, 115522;
tel.: (495) 111-03-03
Competing Interests:
No conflict of interest was declared by the authors.
S. A. Krasovskiy
Russian Federation
Stanislav А. Krasovskiy, Candidate of Medicine, Senior Researcher, Laboratory of Cystic Fibrosis
Author ID: 688178;
Orekhovyy bul’var 28, Moscow, 115682;
tel.: (495) 965-23-24
Competing Interests:
No conflict of interest was declared by the authors.
V. V. Zabnenkova
Russian Federation
Viktoriia V. Zabnenkova, Candidate of Medicine, Laboratory Geneticist
ul. Moskvorechye 1, Moscow, 115522;
tel.: (495) 111-03-03
Competing Interests:
No conflict of interest was declared by the authors.
A. A. Orlova
Russian Federation
Anna A. Orlova, Researcher, Center for Collective Use “Genome”
ul. Moskvorechye 1, Moscow, 115522;
tel.: (495) 111-03-03
Competing Interests:
No conflict of interest was declared by the authors.
G. A. Li
Russian Federation
Georgiy A. Li, Head of the Scientific and Organizational Department
ul. Kominterna 124A, build. 1, Moskovskaya obl., Mytishchi, 141009;
tel.: (495) 111-03-03
Competing Interests:
No conflict of interest was declared by the authors.
O. P. Ryzhkova
Russian Federation
Oxana P. Ryzhkova, Candidate of Medicine, Senior Researcher, Head of the Center for Collective Use “Genome”
ul. Moskvorechye 1, Moscow, 115522;
tel.: (495) 111-03-03
Competing Interests:
No conflict of interest was declared by the authors.
References
1. Kapranov N.I., Kashirskaya N.Y., eds. [Cystic fibrosis]. Moscow: Medpraсtika-M; 2014 (in Russian).
2. Castellani C., Duff A.J.A., Bell S.C. et al. ECFS best practice guidelines: the 2018 revision. J. Cyst. Fibros. 2018; 17 (2): 153–178. DOI: 10.1016/j.jcf.2018.02.006.
3. Mogayzel P.J., Naureckas E.T., Robinson K.A. et al. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am. J. Respir. Crit. Care Med. 2013; 187 (7): 680–689. DOI: 10.1164/rccm.201207-1160oe.
4. Cant N., Pollock N., Ford R.C. CFTR structure and cystic fibrosis. Int. J. Biochem. Cell Biol. 2014; 52: 15–25. DOI: 10.1016/j.biocel.2014.02.004.
5. Melyanovskaya Yu.L., Kondratyeva E.I., Budaeva A.M. [Function of ion channels of epithelial cells in cystic fibrosis]. Pul'monologiya. 2023; 33 (2): 182–188. DOI: 10.18093/0869-0189-2023-33-2-182-188 (in Russian).
6. Bombieri C., Claustres M., De Boeck K. et al. Recommendations for the classification of diseases as CFTR-related disorders. J. Cyst. Fibros. 2011; 10 (Suppl. 2): S86–102. DOI: 10.1016/S1569-1993(11)60014-3.
7. Lucas J.S., Barbato A., Collins S.A. et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur. Respir. J. 2017; 49 (1): 1601090. DOI: 10.1183/13993003.01090-2016.
8. Goutaki M., Papon J.F., Boon M. et al. Standardised clinical data from patients with primary ciliary dyskinesia: FOLLOW-PCD. ERJ Open Res. 2020; 6 (1): 00237-2019. DOI: 10.1183/23120541.00237-2019.
9. Marshall C.B., Mays D.J., Beeler J.S. et al. p73 is required for multiciliogenesis and regulates the Foxj1-associated gene network, cell reports. 2016; 14 (10): 2289–2300. DOI: 10.1016/j.celrep.2016.02.035.
10. Kim D.Y., Sub Y.J., Kim HY. et al. LRRC6 regulates biogenesis of motile cilia by aiding FOXJ1 translocation into the nucleus. Cell Commun. Signal. 2023; 21 (1): 142. DOI: 10.1186/s12964-023-01135-y.
11. Liu S., Chen W., Zhan Y. et al. DNAH11 variants and its association with congenital heart disease and heterotaxy syndrome. Sci. Rep. 2019; 9 (1): 6683. DOI: 10.1038/s41598-019-43109-6.
12. Horani A., Ferkol T.W., Shoseyov D. et al. LRRC6 mutation causes primary ciliary dyskinesia with dynein arm defects. PLoS One. 2013; 8 (3): e59436. DOI: 10.1371/journal.pone.0059436.
13. Behan L., Dimitrov B.D., Kuehni C.E. et al. PICADAR: a diagnostic predictive tool for primary ciliary dyskinesia. Eur. Respir. J. 2016; 47 (4): 1103–1112. DOI: 10.1183/13993003.01551-2015.
14. Kyian T.A., Smirnikhina S.A., Demchenko A.G. et al. [A new software for automated analysis of respiratory tract ciliary epithelium movement for the diagnosis of primary ciliary dyskinesia]. Pul'monologiya. 2024; 34 (2): 184–193. DOI: 10.18093/0869-0189-2024-34-2-184-193 (in Russian).
15. Demchenko A.G., Smirnikhina S.A. [Ciliated cell cultures for diagnosis of primary ciliary dyskinesia]. Pulmonologiya. 2023; 33 (2): 210–215. DOI: 10.18093/0869-0189-2023-33-2-210-215 (in Russian).
16. Lucas J.S., Barbato A., Collins S.A. et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur. Respir. J. 2017; 49 (1): 1601090. DOI: 10.1183/13993003.01090-2016.
17. Kondratyeva E.I., Avdeev S.N., Mizernitskiy Yu.L. et al. [Primary ciliary dyskinesia: review of the draft clinical guidelines, 2022]. Pul'monologiya. 2022; 32 (4): 517–538. DOI: 10.18093/0869-0189-2022–32-4-517-538 (in Russian).
18. Lucas J.S., Barbato A., Collins S.A. et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur. Respir. J. 2017; 49 (1): 1601090. DOI: 10.1183/13993003.01090-2016.
19. Li Y., Li Y., Wang Y. et al. Identification of novel biallelic LRRC6 variants in male Chinese patients with primary ciliary dyskinesia and infertility. J. Assist. Reprod. Genet. 2023; 40 (1): 41–51. DOI: 10.1007/s10815-022-02681-z.
20. Rumman N., Fassad M.R., Driessens C. et al. The Palestinian primary ciliary dyskinesia population: first results of the diagnostic and genetic spectrum. ERJ Open Res. 2023; 9 (2): 00714-2022. DOI: 10.1183/23120541.00714-2022.
Supplementary files
Review
For citations:
Kondratyeva E.I., Kyian T.A., Bragina E.E., Demchenko A.G., Tarasov M.V., Krasovskiy S.A., Zabnenkova V.V., Orlova A.A., Li G.A., Ryzhkova O.P. Late verification of primary ciliary dyskinesia and new diagnostic possibilities. PULMONOLOGIYA. 2025. (In Russ.) https://doi.org/10.18093/0869-0189-2024-4585